Cost effectiveness and cost utility analyses of ivabradine (procoralan®) in the treatment of patients with chronic heart failure in Mexico
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1486
https://www.valueinhealthjournal.com/article/S1098-3015(13)01557-X/fulltext
Title :
Cost effectiveness and cost utility analyses of ivabradine (procoralan®) in the treatment of patients with chronic heart failure in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01557-X&doi=10.1016/j.jval.2013.03.1486
First page :
A286
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1050